GSK Investigational Site
Kaunas LT-51270
1 studies enrolling now · 19 studies all time
What they study most
Arthritis, Rheumatoid, Asthma, Cervical Intraepithelial Neoplasia, Chickenpox, Deep Vein Thrombosis, Diabetes Mellitus, Type 2, Epilepsy, Fibrillation, Atrial, Herpes Simplex, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast
Studies at this site
- A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age — Recruiting now
- A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age — Completed
- Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
- Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old — Completed
- 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
- SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. — Completed
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) — Completed
- The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor — Completed
- Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
- Odiparcil For The Prevention Of Venous Thromboembolism — Completed
- Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
- Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
- Pediatric Epilepsy Study in Subjects 1-24 Months — Completed
- A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma — Completed
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Pediatric Epilepsy Trial in Subjects 1-24 Months — Completed
- Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
- Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed